Dvořáková M., Langhansová L., Temml V., Pavičić A., Vaněk T., Landa P.
ACS MEDICINAL CHEMISTRY LETTERS 12(4): 610-616, 2021

Klíčová slova: Cyclooxygenase, inhibitor, quinazoline, selectivity, docking
Abstrakt: Selective cyclooxygenase-1 (COX-1) inhibition has got into the spotlight with the discovery of COX-1 upregulation in various cancers and the cardioprotective role of COX-1 in control of thrombocyte aggregation. Yet, COX-1-selective inhibitors are poorly explored. Thus, three series of quinazoline derivatives were prepared and tested for their potential inhibitory activity toward COX-1 and COX-2. Of the prepared compounds, 11 exhibited interesting COX-1 selectivity, with 8 compounds being totally COX-1-selective. The IC50 value of the best quinazoline inhibitor was 64 nM. The structural features ensuring COX-1 selectivity were elucidated using in silico modeling.
DOI:
Fulltext: kontaktujte autory z ÚEB
Autoři z ÚEB: Marcela Dvořáková, Přemysl Landa, Lenka Langhansová, Antonio Pavicic, Tomáš Vaněk